For seven thousand years, alcohol survived wars, plagues, prohibition, and economic collapse. What it may not survive is a generation that has quietly decided the cost-to-effect ratio no longer works in its favour.

The financial evidence against the global spirits industry has become increasingly difficult to ignore. Bloomberg data tracking the world’s leading listed alcohol producers shows a decline of approximately forty-six percent from the sector’s June 2021 peak, erasing an estimated $830 billion in combined market capitalization across major listed beer, wine, and spirits companies — a figure widely cited by Reuters, the Financial Times, and multiple equity analysts. Diageo — the Johnnie Walker and Smirnoff parent — has seen its share price decline approximately forty percent since mid-2023, touching a ten-year low. Pernod Ricard, whose brands include Absolut and Jameson, has fared worse still: shares off nearly sixty percent from the same baseline. Rémy Cointreau, Brown-Forman, and Treasury Wine Estates each reported double-digit sales and share-price declines through 2025. Even China’s baijiu colossus Kweichow Moutai — once the world’s most valuable spirits company — now trades more than forty percent below its 2021 high.

The immediate explanation is widely understood: Generation Z drinks less. But that framing, while directionally accurate, is analytically insufficient — and in certain geographies, it is dangerously incomplete.

$830B
Market Value Destroyed
Combined market capitalization erased across top global alcohol producers since the June 2021 peak
54%
U.S. Drinking Rate
Share of American adults who report consuming alcohol — the lowest level since Gallup began tracking in 1939
−46%
Sector Decline
Estimated fall in market capitalization across listed global alcohol producers from the 2021 peak to late 2025, per Bloomberg

I. The Visible Half: Moderation in Developed Markets

How Gen Z Drinking Rates Have Changed Since 2000

In North America and Western Europe, the structural shift is measurable and accelerating. Gallup’s annual tracking survey — conducted in July 2025 across a nationally representative sample of American adults — found that only fifty-four percent of respondents reported consuming alcohol, a four-percentage-point decline from 2024 and eight points below 2023. That figure has fallen below sixty percent fewer than ten times in the survey’s nearly ninety-year history. The consecutive annual declines of this magnitude are, Gallup noted, “unmatched” in its trend data.

Among younger adults specifically, the retreat is sharper and structurally entrenched. A Gallup analysis covering 2021–2023 found that only sixty-two percent of adults under thirty-five reported ever drinking — down ten percentage points from seventy-two percent two decades earlier. Among U.S. college students, the share who abstain entirely rose from twenty percent in 2002 to twenty-eight percent in 2018, with non-college peers showing similar trajectories. The National Institute on Drug Abuse data indicates that lifetime drinking, past-month drinking, and past-year drinking among young Americans began declining around the year 2000 — a trend that has compounded steadily over the intervening quarter century.

Why Gen Z Is Drinking Less: Health, Identity, and the Sober Curious Movement

The motivational architecture of this shift is relatively well-documented. A large share of Gen Z respondents across consumer research surveys cite mental health and wellness as primary factors in their drinking decisions — a finding consistent across multiple independent studies, though the exact figures vary by methodology and sample. The “sober curious” movement — intentional moderation rather than abstinence — has moved from fringe to mainstream positioning. The U.S. Surgeon General’s January 2025 advisory, which highlighted evidence linking alcohol consumption to multiple cancer types, provided institutional reinforcement for what had been a diffuse cultural movement. The World Health Organization’s position that no level of alcohol is “safe” has similarly hardened the health narrative.

The Rise of No-Alcohol and Low-Alcohol Beverages: Market Data and Growth Forecasts

Capital has followed behaviour. The IWSR, the authoritative source on global beverage alcohol data, reports that the no-alcohol segment recruited sixty-one million new buyers between 2022 and 2024 across ten key markets. U.S. no-alcohol beer volumes surged twenty-three percent in 2024, mirroring a twenty-three percent compound annual growth rate over the preceding five years. Global non-alcoholic beer, wine, and spirits sales reached nearly $20 billion in 2023 — double their 2019 level. The IWSR forecasts no-alcohol volumes will grow at a seven percent CAGR through 2028, reaching over eighteen billion servings globally by 2029.

Nexdel Assessment — The Premiumisation Gamble

The industry’s primary response to demand erosion has been premiumisation: shifting product mix toward higher-margin, lower-volume premium spirits, and building no- and low-alcohol product lines. Diageo acquired Ritual Zero Proof. Carlsberg launched a non-alcoholic cider. Moët Hennessy took a stake in French Bloom. AB InBev has set a target of twenty percent global volume from no- and low-alcohol products by 2025.

These are rational tactical responses. They are not structural solutions. Premiumisation works when consumers are trading up within a category. The current dynamic — particularly among younger cohorts — reflects exit from the category, not internal migration. No-alcohol volumes, while growing rapidly in percentage terms, will not offset full-strength declines in absolute volume terms for the foreseeable future. IWSR itself acknowledges this explicitly in its U.S. beer market analysis.

II. The Invisible Half: Substitution Without Oversight

Tramadol Misuse in West Africa: What the Research Shows

The more consequential and less-examined dimension of this realignment is occurring not in the wellness-conscious precincts of London or New York, but in the informal economies of West Africa — where a parallel substance ecosystem has been expanding with significant speed and minimal institutional monitoring.

A peer-reviewed systematic scoping review published in PLOS Global Public Health in January 2024, drawing on eighty-three studies conducted across ten African countries between 2012 and 2023, documented the scope of non-medical tramadol use across the continent. Among young adults and active populations, prevalence rates ranged from 1.9 percent to 77.04 percent across sub-populations — a range that reflects both the genuine variation in use and the measurement challenges inherent in informal markets. Among substance-using undergraduates, tramadol misuse prevalence reached 74.2 percent. Among commercial motorcyclists, the figure was reported at 76 percent. Seventy-seven percent of the studies in the review were concentrated in Nigeria and Egypt, reflecting both the scale of populations and the apparent scale of the market.

How Drug Enforcement in Nigeria Created the Conditions for an Illicit Opioid Market

The supply-side dynamics reveal the structural logic of the phenomenon. Research published in the journal Drugs, Habits and Social Policy, based on in-depth interviews with commercially oriented drug dealers in Uyo, Nigeria, found that enforcement-based approaches did not curtail opioid supply. Instead, police actions constrained access to legitimate pain medication while simultaneously encouraging the development of illegal markets — and, critically, generating law enforcement corruption through police complicity in tramadol trading. The regulated system, by attempting to close itself, created the infrastructure for its unregulated alternative.

Nitrous Oxide Use Among Nigerian Youth: An Emerging Public Health Problem

Nitrous oxide has emerged as a secondary concern. Media reports and agency data reviewed by researchers indicate that Nigerian youth use nitrous oxide recreationally, primarily in party settings. Academic literature characterises this as an “emerging public health problem” — one that warrants empirical attention but remains under-researched at scale, meaning the scope of use is not yet fully quantifiable through peer-reviewed evidence.

In West Africa, enforcement-based drug control gained traction through public concerns about opioid misuse, but faced resistance due to the persistence of non-medical use and illegal supply channels made possible by law enforcement complicity.

Nelson, Odeigah & Dumbili — Drugs, Habits and Social Policy, 2023

The economic logic is straightforward, if disturbing. In inflationary environments where household purchasing power is under sustained pressure, alcohol — which is relatively expensive per unit of psychoactive effect and heavily taxed in formal markets — faces competition from pharmaceutical opioids and inhalants that deliver faster, more intense effects at lower cost. A systematic review of substance use across West Africa, published in PLOS Global Public Health in late 2024 and covering 43,145 participants across 22 studies, found tramadol prevalence at thirty percent among substance-using populations surveyed — not the general population — and codeine at eleven percent. The figures reflect use within specific study samples, not baseline population rates, but they indicate the depth of penetration within the cohorts most exposed to these conditions.

III. The Structural Drivers of a Two-Speed Divergence

Three interlocking forces explain why global youth consumption is bifurcating rather than declining uniformly.

Cost-to-Effect Optimisation: Why Cheaper Alternatives Win in Inflationary Economies

The first is cost-to-effect optimisation. Alcohol occupies a mid-range position in the pharmacological value chain: it produces psychoactive effects, but at a relatively high financial cost per unit of effect in markets where it is taxed and regulated. As inflation compressed discretionary spending — U.S. consumers are spending twenty-two percent more for eight percent less in grocery baskets compared to four years ago, Jefferies analysts noted in their Diageo assessment — the economic case for a cheaper, faster-acting alternative strengthened considerably for economically constrained consumers in emerging markets.

Regulatory Arbitrage: How Formal Alcohol Markets Drive Demand Toward Informal Substances

The second driver is regulatory arbitrage. Alcohol markets are among the most intensively regulated consumer goods categories in the world: they carry excise taxes, age restrictions, licensing requirements, and monitored distribution chains. Informal pharmaceutical and inhalant markets operate outside all of these constraints. The result is that consumption migrates toward what is accessible rather than toward what is safer — a pattern well-documented in public health literature, replicated now at macro scale.

Youth Unemployment and Poverty in Sub-Saharan Africa: The Structural Backdrop to Substance Use

The third factor is the socioeconomic context of youth in sub-Saharan Africa specifically. The ILO’s 2024 Global Employment Trends for Youth report noted that unemployment rates in North Africa reached 22.5 percent in 2024, with youth unemployment classified as “critically high.” Nearly three-quarters of young adults in sub-Saharan Africa are in insecure employment. The Mastercard Foundation’s Africa Youth Employment Outlook 2026 found that as of 2025, nearly as many 15-to-17-year-olds across the continent were working as were studying — mostly in informal, low-paying roles, with forty percent living below the $2.15-per-day international poverty line. One in three of the 304 million young workers on the continent lives in a household categorised as extremely poor.

This is the structural substrate within which substance use decisions are made. The academic literature indicates a consistent correlation: unemployed individuals and low-income earners show intensified tramadol misuse across the studies reviewed. Research from Ghana found that those with secondary and tertiary education were thirty-six and forty-two percent less likely, respectively, to engage in severe tramadol misuse compared to those with basic or no formal education. The substance use pattern is not pathological in isolation — it appears, across the available evidence, to reflect a response to structural conditions that the market narrative on Gen Z sobriety does not account for.

IV. A Market Reading the Wrong Signal

Developed Markets vs. African Emerging Markets: A Comparative Framework

DimensionDeveloped Markets VisibleEmerging Markets — Africa Undertracked
Primary behaviourModeration, abstinence, wellness repositioningSubstitution toward unregulated substances
Substitutes emergingNon-alcoholic beer/spirits, functional drinks, RTDsNon-medical tramadol, codeine, nitrous oxide
Regulatory visibilityHigh — formal retail, taxed, trackedMinimal — informal markets, outside excise systems
Primary driverHealth consciousness, identity signalling, wellness cultureCost-to-effect ratio, structural poverty, regulatory arbitrage
Industry responsePremiumisation, no-alcohol product lines, brand repositioningNone — outside category mapping entirely
Health trajectoryBroadly positive, with caveats around alcohol-adjacent functional drinksAdverse — dependency syndromes, withdrawal effects, unregulated dosing
Priced into markets?PartiallyNo

The industry’s measurement problem is fundamental. A significant portion of psychoactive consumption in emerging markets occurs outside formal retail channels, without taxation or reporting, and beyond the reach of standard industry analytics. Direct system-wide measurement of total psychoactive consumption remains limited, meaning the extent of substitution cannot yet be quantified at a macro level. What can be said is that recorded alcohol demand declines while the academic evidence on informal substance use points in the opposite direction. For investors assessing demand destruction and for public health policymakers designing intervention frameworks, that gap is not semantic. It reframes the phenomenon from a category decline into a possible system-level displacement — with materially different implications in each case.

Is the Alcohol Industry’s Decline Structural or Cyclical? The Tobacco Parallel

Sarah Simon of Morgan Stanley, who currently holds more underweight recommendations in beverages than in any other European consumer staples category, described the current downturn as structural rather than cyclical. Andrew Gowen of Bell Asset Management characterised comparisons between the alcohol and tobacco industries as “unthinkable five years ago” — a comparison now appearing with increasing frequency in institutional equity research. The tobacco parallel is instructive: cigarette volume declines in the United States began following the Surgeon General’s 1964 advisory and proved to be permanent. The current trajectory of alcohol consumption — at its lowest recorded level in the U.S. since the Great Depression era — raises the possibility of a similar long-duration demand shift, though the structural drivers of each are distinct.

V. Implications Across Three Vectors

What the Global Alcohol Demand Shift Means for Corporations, Regulators, Health Systems, and Investors

Corporate Strategy

Brand-driven consumption models built on aspirational signalling are under structural erosion. Companies operating through regulated distribution channels face inherent limits to recapturing demand that has migrated to informal substitutes. The no-alcohol pivot addresses the visible segment of the trend while leaving the displacement segment entirely untouched. Capital allocation toward emerging market volume recovery should be stress-tested against informal substitution dynamics that do not appear in addressable market models.

Public Health Systems

A shift from regulated alcohol toward unregulated pharmaceutical opioids and inhalants introduces substantially higher volatility in health outcomes. Alcohol’s harms — while significant — occur within a system of dosage standards, supply chain monitoring, and clinical recognition. Non-medical tramadol misuse involves inconsistent dosing, unknown supply chains, and dependency syndromes that are clinically complex to manage in resource-constrained health systems. The health burden is not falling — it is migrating upward in severity.

Regulatory Frameworks

Traditional regulatory architecture — excise systems, age restrictions, licensing — was designed around alcohol and tobacco, two categories with formalised supply chains. The current consumption reallocation is occurring into a space that existing frameworks cannot effectively reach. Enforcement-only approaches, as the Nigerian evidence demonstrates, tend to constrain the legitimate market while stimulating the illicit one. New frameworks will require harm reduction models and decriminalised engagement with users and supply chains.

Investor Positioning

Equities in the global alcohol sector are now trading at approximately fifteen times forward earnings — less than half their 2021 valuation. The structural question for long-duration investors is whether the moderation trend in developed markets represents a mean-reverting cyclical dip or a permanent recalibration of the category. The Gallup data — consecutive, multi-year, across all demographic cohorts — reads closer to the latter. The tobacco analogy does not resolve this question, but it sharpens the framing of terminal value assumptions in conventional DCF models.

■ Strategic Assessment
Reallocating, Not Abstaining

Generation Z is not uniformly abstinent. What the available evidence suggests — taken together, though not yet proven as a single connected chain — is that the generation is reallocating psychoactive consumption on the basis of cost, access, identity, and intensity, in ways that differ sharply by geography and socioeconomic circumstance. In one segment, that reallocation produces the sober-curious wellness consumer that industry analysts have been studying intently. In another, it appears to produce an unregulated and clinically risky substitution pattern that is virtually absent from the market conversation.

The critical structural question for both executives and regulators is not whether Gen Z will reshape consumption patterns. That question appears increasingly settled in the data. The question is: what happens when a generation exits regulated systems faster than new institutional structures can be built to absorb the consequences? Alcohol companies are optimising for the part of the answer visible in their data. The rest of the answer is playing out in West African markets, in informal pharmacies, and in a body of academic literature that has not yet found its way into an earnings call.

This analysis is based on publicly available data from Bloomberg, Gallup, IWSR, PLOS Global Public Health, the International Labour Organization, the Mastercard Foundation, and peer-reviewed academic literature. Nexdel Intelligence does not hold positions in any securities referenced herein.

Primary Sources & References